| |
|
|
|
|
|
|
|||
|
Blood, 27 August 2009, Vol. 114, No. 9, pp. 1727-1728.
The antitumorigenic trifectaDUKE UNIVERSITY Abstract The laboratory of Judah Folkman identified the potent endogenous antiangiogenic protein angiostatin in 1994.1 In this issue of Blood, Lee and colleagues propose 2 new mechanisms of action for angiostatin that may represent promising targets for new cancer therapeutics.2
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||